Navigation Links
Semler to Report Second Quarter 2014 Financial Results and Host Conference Call on July 25, 2014
Date:7/22/2014

PORTLAND, Ore., July 22, 2014 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR; "Semler"), an emerging medical risk assessment company that develops patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced that it will report second quarter 2014 financial results before the open of U.S. financial markets on July 25, 2014. Doug Murphy-Chutorian, M.D., chief executive officer of Semler will host a conference call at 11 a.m. EDT, July 25, 2014.

The conference call may be accessed by dialing 877-359-9508 for domestic callers and 224-357-2393 for international callers. Please specify to the operator that you would like to join the "Semler Second Quarter 2014 Financial Results Call, conference ID#: 78080334." The conference call will be archived on Semler's website at semlerscientific.com.

About Semler Scientific, Inc.:
Semler Scientific, Inc. is an emerging medical risk-assessment company.  Its mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Semler's first patented and U.S. Food and Drug Administration, or FDA, cleared product, is FloChec®. FloChec® is used in the office setting to allow providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians for whom it was previously impractical to conduct blood flow measurements. FloChec® received FDA 510(k) clearance in February 2010, Semler began Beta testing in the third quarter of 2010, and Semler began commercially leasing FloChec® in January 2011. Semler closed the initial public offering of its common stock on Febr
'/>"/>

SOURCE Semler Scientific, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
7. Pharmasset Reports Fiscal Year End 2011 Financial Results
8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
10. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
11. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... RESTON, Va. (PRWEB) October 24, 2014 ... (WEDI), the nation’s leading nonprofit authority on ... in healthcare information exchange, announces its appointment of ... Privacy Workgroup. The workgroup leaders include:, ... Optum ,     Erik Pupo, Specialist Leader, Deloitte ...
(Date:10/25/2014)... Addison, TX (PRWEB) October 24, 2014 ... skincare products, announced the winners of its “Reflect Your ... who have not only seen a difference in their ... also experienced a new outlook on life as a ... Youth” contest originated as an effort by Nerium International ...
(Date:10/25/2014)... 2014 A new way to produce ... of current skin grafting technologies, it also speeds up ... method, outlined in the October issue of STEM CELLS ... skin injuries that result from severe burns and chronic ... skin’s regenerative elements. These wounds heal by contraction, with ...
(Date:10/25/2014)... , October 24, 2014 ... clinical-stage pharmaceutical company focused on the development of oral ... Nadav Kidron will present at FireRock Capital,s ... Capital,s Annual Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ... New York City , ...
Breaking Biology Technology:WEDI Appoints Four New Security and Privacy Workgroup Co-chairs 2Nerium International™ Inspires Conversation About the Journey of Aging with “Reflect Your Youth” Contest 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 3Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3
... BELMONT, Calif., March 5, 2012  Phalanx Biotech Group, ... the OneArray® line of open-platform microarrays for whole ... several new product launches in 2011, Phalanx Biotech ... markets.  "2011 proved to be a very busy ...
... scientists at the U.S. Department of Energy,s Lawrence Berkeley National ... of gold mere nanometers (billionths of a meter) thick were ... to cool. They watched in surprise as peculiar features expanded ... settling into circles surrounded by irregular blisters. The ...
... an earthquake and tsunami hit Japan on March ... country,s failures in disaster planning and crisis management for ... The article, out now in the Bulletin of ... agencies were thoroughly unprepared for the cascading nuclear disaster, ...
Cached Biology Technology:Phalanx Biotech Group Reports Robust Revenue Growth in 2011 2Solved: The mystery of the nanoscale crop circles 2Solved: The mystery of the nanoscale crop circles 3Solved: The mystery of the nanoscale crop circles 4Fukushima 1 year on: Poor planning hampered Fukushima response 2Fukushima 1 year on: Poor planning hampered Fukushima response 3
(Date:10/16/2014)... – Post-menopausal women experienced improvements in vaginal atrophy, ... genital bleeding, after 12 weeks of daily 10 ... germ-based nutritional supplement previously shown to help relieve ... pilot study reported in a poster at the ... , "These data documented improved vaginal epithelium, ...
(Date:10/15/2014)... 15, 2014 Sandata Technologies, LLC, an ... community-based care, today announced it released a case ... Electronic Visit Verification™ Solution (EVV™)  for Quality Care ... health company founded in 1996 and has five ... The study details the challenges facing ...
(Date:10/15/2014)... ,Models of Life, is a non-traditional biophysics textbook and ... book is a journey of discovery into biological systems ... and biological regulation. It is about how our genes ... between the billions of cells in an organism. It ... between principles, which can be found on both large ...
Breaking Biology News(10 mins):S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2Sandata Announces Case Study with Quality Care Services, Inc. 2New book about life as seen from physics 2
... technologies, such as siRNA, tap into endogenous, highly ... gene expression. As such, they have the potential ... for disease targets previously considered un-druggable by conventional ... promise, clinical development has been hindered by the ...
... BiOptix announces the appointment of Michael W. Routh, Ph. D. ... a preeminent group of leaders driving BiOptix and its proprietary ... in the life science marketplace. BiOptix, a leader ... of Michael W. Routh, Ph.D. to the Board of Directors.  ...
... President Barack Obama introduced the Materials Genome Initiative (MGI) ... University when he announced the Advanced Manufacturing Partnership. The ... deploy advanced materials at twice the speed than is ... Global Competitiveness" released by the White House Office of ...
Cached Biology News:Oligonucleotide Delivery: Biology, Engineering and Development Conference 2Oligonucleotide Delivery: Biology, Engineering and Development Conference 3BiOptix announces expansion of Board of Directors 2Harnessing the Materials Genome Conference 2Harnessing the Materials Genome Conference 3Harnessing the Materials Genome Conference 4Harnessing the Materials Genome Conference 5
... Synthetic peptide derived from the internal ... Specificity: Specific for the junctophilin-1 protein. ... brain and skeletal muscle homogenates frozen ... Applications: Western blotting Immunohistochemistry(froz) ImmunofluorescenceStorage: ...
Laminin beta-1/gamma-1 (612C10)...
100 ug affinity purified rabbit anti-JIP-1 polyclonal antibody. Reacts with mouse and rat. Perform well in Western blotting. Other applications have not been tested. Storage Temperature: -20C Shi...
XBP-1 (F-4)...
Biology Products: